These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10423974)

  • 1. [The first rotavirus vaccine approved in the USA and Europe].
    Svensson L; Johansen K; Uhnoo I
    Lakartidningen; 1999 Jun; 96(26-27):3158-60. PubMed ID: 10423974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rotavirus vaccines: new drug. Rotavirus infection: one case of severe diarrhoea prevented per 100 vaccinated infants.
    Prescrire Int; 2007 Feb; 16(87):3-6. PubMed ID: 17323513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiologic background for the need of rotavirus vaccine in Finland. Preliminary experience of RIT 4237 strain of live attenuated rotavirus vaccine in adults.
    Vesikari T; Mäki M; Isolauri E
    Dev Biol Stand; 1983; 53():229-36. PubMed ID: 6307778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A vaccine against diarrhea. Soon a reality in the fight against viral gastroenteritis in both developed and developing countries].
    Svensson L
    Lakartidningen; 1996 Jan; 93(5):353-8. PubMed ID: 8628065
    [No Abstract]   [Full Text] [Related]  

  • 5. Rotavirus live, oral, pentavalent vaccine.
    Tom-Revzon C
    Clin Ther; 2007 Dec; 29(12):2724-37. PubMed ID: 18201590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vaccination against rotavirus in Uzbekistan?].
    Gjersvik P
    Tidsskr Nor Laegeforen; 2006 Oct; 126(20):2694. PubMed ID: 17066540
    [No Abstract]   [Full Text] [Related]  

  • 7. [Rotavirus laboratory network: results after one year of observation].
    Bok K; Castagnaro NC; Diaz NE; Borsa A; Cagnoli MR; Nates S; Yudowsky S; Espul C; Cuello H; Fay O; Brunet B; Ues OC; Santoro R; Grinstein S; Gonzalez F; Miceli I; Gomez JA
    Rev Argent Microbiol; 1999; 31(1):1-12. PubMed ID: 10327454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of a rotavirus vaccine. Field trials in Venezuela].
    Pérez Schael I; Rojas Mazzei AM; Flores J
    Acta Cient Venez; 1991; 42(6):296-312. PubMed ID: 1668865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rotavirus vaccines and intussusception risk.
    Bines JE
    Curr Opin Gastroenterol; 2005 Jan; 21(1):20-5. PubMed ID: 15687880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rotavirus vaccination coverage and adherence to the Advisory Committee on Immunization Practices (ACIP)-recommended vaccination schedule--United States, February 2006-May 2007.
    ;
    MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(15):398-401. PubMed ID: 18418345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RotaTeq: a three-dose oral pentavalent reassortant rotavirus vaccine.
    Chandran A; Santosham M
    Expert Rev Vaccines; 2008 Dec; 7(10):1475-80. PubMed ID: 19053204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rotavirus vaccine, live, oral, tetravalent (RotaShield).
    Hochwald C; Kivela L
    Pediatr Nurs; 1999; 25(2):203-4, 207. PubMed ID: 10532018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rotavirus vaccines: targeting the developing world.
    Glass RI; Bresee JS; Turcios R; Fischer TK; Parashar UD; Steele AD
    J Infect Dis; 2005 Sep; 192 Suppl 1():S160-6. PubMed ID: 16088799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A vaccine against rotavirus--when is too much too much?
    Keusch GT; Cash RA
    N Engl J Med; 1997 Oct; 337(17):1228-9. PubMed ID: 9337384
    [No Abstract]   [Full Text] [Related]  

  • 15. The pentavalent rotavirus vaccine, RotaTeq.
    Matson DO
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):195-9. PubMed ID: 17055370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rotavirus vaccine.
    Offit PA
    J Clin Virol; 1998 Dec; 11(3):155-9. PubMed ID: 9949951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rotavirus serotype G9 is associated with more-severe disease in Latin America.
    Linhares AC; Verstraeten T; Wolleswinkel-van den Bosch J; Clemens R; Breuer T
    Clin Infect Dis; 2006 Aug; 43(3):312-4. PubMed ID: 16804845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost and cost-effectiveness of childhood vaccination against rotavirus in France.
    Melliez H; Levybruhl D; Boelle PY; Dervaux B; Baron S; Yazdanpanah Y
    Vaccine; 2008 Jan; 26(5):706-15. PubMed ID: 18166250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age dependence of the relation between reassortant rotavirus vaccine (RotaShield) and intussusception.
    Rothman KJ; Young-Xu Y; Arellano F
    J Infect Dis; 2006 Mar; 193(6):898; author reply 898-9. PubMed ID: 16479526
    [No Abstract]   [Full Text] [Related]  

  • 20. Rotavirus serotypes: classification and importance in epidemiology, immunity, and vaccine development.
    Hoshino Y; Kapikian AZ
    J Health Popul Nutr; 2000 Jun; 18(1):5-14. PubMed ID: 11014764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.